S F Davis
Overview
Explore the profile of S F Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arcury T, Feldman S, Schulz M, Vallejos Q, Verma A, Fleischer Jr A, et al.
J Agric Saf Health
. 2007 Dec;
13(4):407-18.
PMID: 18075016
Skin diseases are common among farmworkers, yet little research documents their prevalence and risk factors. This analysis documents the prevalence of skin diseases among farmworkers in North Carolina, examines variation...
2.
Davis S, Linn C
Am J Physiol Cell Physiol
. 2002 Nov;
284(3):C757-68.
PMID: 12456395
Catfish (Ictalurus punctatus) cone horizontal cells contain N-methyl-d-aspartate (NMDA) receptors, the function of which has yet to be determined. In the present study, we have examined the effect of NMDA...
3.
Smith B, Davis S, van den Pol A, Xu W
Neuroscience
. 2002 Nov;
115(3):707-14.
PMID: 12435409
Hypocretin 2 (orexin B) is a hypothalamic neuropeptide thought to be involved in regulating energy homeostasis, autonomic function, arousal, and sensory processing. Neural circuits in the caudal nucleus tractus solitarius...
4.
Streiff N, Feurer I, Speroff T, Davis S, Butler J, Chomsky D, et al.
Transplant Proc
. 2001 Dec;
33(7-8):3533-5.
PMID: 11750505
No abstract available.
5.
Stock K, Scott M, Davis S, Pierson 3rd R, Dummer J
Transpl Int
. 2001 Mar;
14(1):44-7.
PMID: 11263555
Infection due to enterohemorrhagic Escherichia coli (EHEC) has not been described in immunosuppressed patients. We recently saw a case of EHEC infection caused by a novel Shiga toxin II-producing Escherichia...
6.
Eisen H, Hobbs R, Davis S, Carrier M, Mancini D, Smith A, et al.
Transplantation
. 2001 Feb;
71(1):70-8.
PMID: 11211198
Background: The widespread use of cyclosporine has improved the survival of cardiac transplant patients as a result of reduced morbidity and mortality from rejection and infection. The original oil-based form...
7.
Denton M, Davis S, Baum M, Melter M, Reinders M, Exeni A, et al.
Pediatr Transplant
. 2000 Nov;
4(4):252-60.
PMID: 11079263
In this review, we discuss the role of the allograft endothelium in the recruitment and activation of leukocytes during acute and chronic rejection. We discuss associations among endothelial activation responses,...
8.
Kollar A, Donaldson T, Greer E, Howser R, Davis S, Drinkwater Jr D
Prog Transplant
. 2000 Aug;
10(1):18-20.
PMID: 10941322
A case of heart transplantation with concomitant coronary artery bypass graft is reported. The patient was an alternate transplant list candidate with a history of bilateral below-knee amputation and 2...
9.
Miller G, Davis S, Atkinson J, Chomsky D, Pedroso P, Reddy V, et al.
Circulation
. 1999 Dec;
100(24):2396-9.
PMID: 10595950
Background: Vascular smooth muscle cell growth factors are postulated to contribute to cardiac allograft vasculopathy (CAV). Few data quantitatively address the timing, location, or stimuli for growth factor expression and...
10.
Eisen H, Hobbs R, Davis S, Laufer G, Mancini D, Renlund D, et al.
Transplantation
. 1999 Oct;
68(5):663-71.
PMID: 10507486
Background: The introduction of cyclosporine has resulted in significant improvement in the survival of cardiac allograft recipients due to decreased mortality from infection and rejection. The original oil-based cyclosporine formulation...